The mechanism of statin enhanced radiosensitivity in lung cancer was mediated by inhibiting the PI3K/AKT and activating the tumor suppressor AMP-activated kinase (AMPK) pathway (Sanli et al., 2011). This evidence concerns the gene AKT1 and lung cancer.